How Training Enables Companies to Get the Most Value from Digital Transformation

whitePaper | July 1, 2022

Data is an extremely valuable asset in today’s world. After all, there are entire industries based on it. Because of this, it’s important to evangelize the value of data within your organization.

whitePaper | September 2, 2022

This year, unlike previous years, we asked professionals the most difficult elements of a successful data strategy instead of the most important.

whitePaper | August 12, 2021

This BARC Score report will evaluate BI & analytics platforms on a range of features, from data visualization capabilities to semantic modeling abilities, performance and speed to automation capabilities.

whitePaper | September 12, 2022

Clinical Data Management (CDM) evolved over the last two decades from managing data entered on paper Case Report Forms (CRFs) to managing data transcribed into Electronic Data Capture (EDC) systems. The Society for Clinical Data Management (SCDM) strongly contributed to this first significant CDM evolution through its Good Clinical Data Management Practice 1 (GCDMP©) Chapters first published in 2000 and its certification program for Clinical Data Managers2 subsequently released in 2004.

whitePaper | February 24, 2022

Today’s business relies on access to critical data more than ever to remain ahead of the competition. Due to the challenges over the last two years, organizations must respond to greater demand for data access and a shift to supporting AI/ML in a complex, hybrid multi-cloud environment. Organizations need to become nimble in providing fast, reliable access to data anytime, anywhere, throughout their increasingly complex, integrated enterprise.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.